reserve pacing capabilities. The incidence of postcardioversion/defibrillation bradycardia necessitating pacing and the incidence of supraventricular tachyarrhythmias or nonsustained ventricular tachycardia that could inappropriately retrigger the automatic device are unknown. In addition, the nature and duration of QRS-T changes after cardioversion/defibrillation for ventricular arrhythmias in a patient population characterized by severe coronary artery disease are unknown.
THE NUMBER OF PATIENTS undergoing implantation of automatic cardioverting and/or defibrillating devices for life-threatening ventricular arrhythmias is increasing.1`Most of the current devices do not have reserve pacing capabilities. The incidence of postcardioversion/defibrillation bradycardia necessitating pacing and the incidence of supraventricular tachyarrhythmias or nonsustained ventricular tachycardia that could inappropriately retrigger the automatic device are unknown. In addition, the nature and duration of QRS-T changes after cardioversion/defibrillation for ventricular arrhythmias in a patient population characterized by severe coronary artery disease are unknown.
Using serial surface 12-lead, continuous-surface threelead, and intracardiac electrocardiographic recordings we determined (1) the incidence of brady-and tachyarrhythmias and (2) the incidence and duration of QRS-T changes after external and/or automatic internal cardioversion/defibrillation for induced ventricular arrhythmias. In addition, the relationship of brady-and tachyarrhythmias and QRS-T changes to the presence and location of coronary artery disease, type and duration of induced arrhythmia, delivered energy, and the presence of cardioactive medications was assessed.
Methods
Patients. Fifty-six patients, 46 men and 10 women with a mean age of 60 years, were prospectively studied at the time of electrophysiologic testing for documented or suspected ventricular arrhythmias. Ventricular automatic internal cardioverter/defibrillator was uniformly successful in terminating the ventricular arrhythmia. Bradyarrhythmias (tables 3 to 5). The mean ventricular cycle length during the first 5 sec after cardioversion was 984 + 414 msec. There was no statistical difference in the incidence of bradycardia after external vs internal cardioversion (table 3) . Among the 16 patients who developed early bradycardia, nine had cycle lengths that continued to be greater than 1000 msec at 10 sec. Pacing was instituted by 9 to 12 sec in four patients, all of whom were externally cardioverted. In the remaining five patients, cycle lengths decreased to less than 1000 msec by 20 sec. Postcardioversion bradyarrhythmias included sinus bradycardia in six patients, idioventricular rhythm with subsequent sinus bradycardia in eight patients, and atrial fibrillation with a slow ventricular response (mean cycle lengths 1920 and 2650 msec) in two patients.
Early bradycardia after external cardioversion was more common when multiple shocks were required for termination of arrhythmia (table 5 ). In addition, early bradycardia occurred more commonly in the setting of previous inferior myocardial infarction (table 4) . Notably, all five patients with inferior myocardial infarctions who required multiple cardioversions had early bradycardia. Thus, these factors could not be demonstrated to be independently related to the development of bradycardia. Furthermore, bradycardia was not related to induced arrhythmia, cardioactive medications, duration of arrhythmia, or baseline heart rate (tables 4 and 5). The addition of internal cardioversions to the external data did not affect the relationship of any 12 (13) 31 (41) 5 (6) 16 (17) 5 (7) 11 (17) 12 (12) 36 (41) 6 (6) 9 (9) 11 (13) 38 (49) 6 (6) 12 (12) 11 (13) 35 (46) 3 (3) 7 (7) 17 (22) 37 (45) 14 (17) 29 (37) 6 (8) 15 (15) 7 (12) 13 (13) 9 (12) 35 (40) 5 (5) 10 (10) 15 (20) 34 (42) Not evaluated CV -cardioversion.
ANumbers without parentheses refer to extemal CV events (n = 64) and numbers in parentheses refer to internal and external CV events (n = 77). Reproducibility. Sixteen patients in this study were cardioverted on more than one occasion after separate induction of ventricular arrhythmias: 10 patients externally, three patients internally, and three patients extemally and internally, before and after implantation of the automatic internal cardioverter/defibrillator. Arrhythmias. Of the 10 patients with repeated external cardioversions, nine had comparable sinus or atrial rhythms and ventricular cycle lengths in the first 5 sec after cardioversion (mean cycle length difference 117 + 94 msec). The three patients internally cardioverted were in sinus rhythms and had comparable mean cycle lengths early after cardioversion (942 vs 840 msec, 908 vs 908 msec, and 1980 vs 1116 msec). Two of three patients who were externally and internally cardioverted were in sinus rhythm and had comparable mean cycle lengths after cardioversion (952 vs 765 msec, 1065 vs 1000 msec). The third patient developed atrial flutter after external cardioversion and normal sinus rhythm after internal cardioversion. The development of nonsustained ventricular tachycardia was not reproducible in the two patients who underwent more than one cardioversion and in whom this rhythm was noted.
QRS-T changes. Of the 10 patients externally cardioverted more than once, six had the same ST changes with respect to their presence and location We have previously found no evidence of increases in creatine kinase-B isoenzyme levels in a similar population of patients who had no persistent electrocardiographic changes after emergent cardioversion of induced ventricular arrhythmias.i6 Longer lasting ST changes may be associated with ischemic injury. This study demonstrates that in patients with induced and poorly tolerated ventricular arrhythmias (1) external cardioversion of ventricular tachycardia but not ventricular fibrillation is successful with 200 Wsec of energy, (2) the incidence of arrhythmias and ST changes appear comparable after external and internal cardioversion, (3) bradycardia immediately after cardioversion is common and appears to be associated with a previous history of inferior infarction and the need for repeated cardioversion to terminate the arrhythmia, (4) supraventricular tachycardias, usually sinus (rates > 120 beats/min) are also common after cardioversion, although rates of more than 150 beats/ min are unusual, (5) nonsustained ventricular tachycardia of sufficient duration and rate to trigger the current automatic cardioverter/defibrillator occurs after approximately 5% of cardioversions, and (6) ST segment and T wave changes are common after cardioversion but rarely persist longer than 5 min. These results suggest that energy levels greater than 200
Wsec should be considered for the first attempt at countershock of induced ventricular fibrillation. In addition, our observations may have implications regarding the need for backup pacing and tachycardia triggering rates for automatic cardioverting/defibrillating devices and for the diagnosis of ischemic electrocardiographic changes after cardioversion of induced arrhythmias.
